Theriva Biologics, Inc. Conversion of Stock, Shares Converted
Theriva Biologics, Inc. (TOVX) reported Conversion of Stock, Shares Converted of 7.90 thousand shares for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2019-08-08
- Theriva Biologics, Inc. conversion of stock, shares converted for the quarter ending 2019-06-30 was 302.00 shares.
- Theriva Biologics, Inc. conversion of stock, shares converted for the quarter ending 2019-03-31 was 7.60K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month |
|---|---|---|
| 2019-06-30 | 302.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 7.90K shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 7.60K shares 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |